Anika Therapeutics

ANIK · NASDAQ

$20.44+$0.22 (+1.09%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $20.22

Latest news

Press releaseAug 4, 9:05 AM ETGlobe Newswire
Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One
NewsJul 29, 8:05 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Press releaseJul 29, 7:05 AM ETGlobe Newswire
Anika Reports Second Quarter 2026 Financial Results
NewsApr 29, 1:05 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
NewsApr 29, 7:11 AM ET
Earnings Scheduled For April 29, 2026
NewsApr 29, 7:07 AM ET
Anika Therapeutics Q1 Adj. EPS $0.27 Beats $(0.16) Estimate, Sales $29.612M Beat $28.142M Estimate
Press releaseApr 29, 7:05 AM ETGlobe Newswire
Anika Reports First Quarter 2026 Financial Results
Press releaseApr 16, 7:30 AM ETGlobe Newswire
Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors
Press releaseApr 8, 6:44 PM ETGlobe Newswire
Telix Strengthens Board with Additional Director Appointments
NewsMar 23, 8:05 AM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
NewsFeb 26, 7:08 AM ET
Insights into Anika Therapeutics Q4 Earnings
NewsFeb 26, 7:07 AM ET
Anika Therapeutics Q4 Adj. EPS $0.31 Beats $(0.21) Estimate, Sales $30.615M Beat $28.875M Estimate
Press releaseFeb 26, 7:05 AM ETGlobe Newswire
Anika Reports Fourth Quarter and Full Year 2025 Financial Results
Press releaseFeb 4, 8:54 AM ETPRNewswire
Lumicell Appoints Biotech and Medtech Leader Cheryl R. Blanchard, Ph.D., to Board of Directors
Press releaseJan 26, 5:16 PM ETGlobe Newswire
ANIKA INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Reminds Anika Therapeutics Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Anika Stockholders
Press releaseJan 23, 8:00 PM ETBusiness Wire
ANIK INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Anika Therapeutics, Inc.
NewsJan 8, 7:10 AM ET
CFO And COO Steve Griffin to Take Over as Anika CEO While Cheryl Blanchard Becomes Executive Chair
Press releaseJan 8, 7:00 AM ETGlobe Newswire
Anika Therapeutics Announces Leadership Transition
Press releaseDec 30, 6:00 PM ETBusiness Wire
ANIK Investigation: Investors Encouraged to Contact Kirby McInerney LLP
Press releaseDec 5, 8:00 PM ETGlobe Newswire
Anika Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors ANIK
Press releaseNov 5, 7:05 AM ETGlobe Newswire
Anika Reports Third Quarter 2025 Financial Results
Press releaseOct 9, 12:45 PM ETGlobe Newswire
ANIKA INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Reminds Anika Therapeutics Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Anika Stockholders
Press releaseSep 25, 5:43 PM ETGlobe Newswire
ANIKA (ANIK) ALERT: Bragar Eagel & Squire, P.C. is Investigating Anika Therapeutics, Inc. on Behalf of Anika Stockholders and Encourages Investors to Contact the Firm
Press releaseSep 14, 10:00 AM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Anika Therapeutics, Inc. – ANIK
Press releaseSep 13, 10:00 AM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
Press releaseSep 10, 2:50 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
Press releaseSep 8, 3:30 PM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
Press releaseSep 6, 10:00 AM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
Press releaseSep 3, 10:00 AM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
Press releaseSep 2, 10:00 AM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
Press releaseAug 29, 10:05 AM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
Press releaseAug 27, 10:00 AM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
Press releaseAug 26, 4:12 PM ETGlobe Newswire
ANIKA ALERT: Bragar Eagel & Squire, P.C. is Investigating Anika Therapeutics, Inc. on Behalf of Anika Stockholders and Encourages Investors to Contact the Firm
Press releaseAug 22, 10:00 AM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
Press releaseAug 21, 2:17 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
Press releaseAug 20, 4:57 PM ETGlobe Newswire
Bragar Eagel & Squire, P.C. Is Investigating Nutex, Anika, Fluor, and Inspire Medical and Encourages Investors to Contact the Firm
Press releaseAug 16, 10:00 AM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
Press releaseAug 13, 11:00 AM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
Press releaseAug 12, 7:34 PM ETGlobe Newswire
ANIKA (ANIK) ALERT: Bragar Eagel & Squire, P.C. Continues Investigating Anika Therapeutics, Inc. on Behalf of Anika Stockholders and Encourages Investors to Contact the Firm
NewsMar 13, 5:52 AM ETRishabh Mishra
US Stocks Likely To Open Lower After A Brief Respite: 'Add Exposure To Equities' Amid Pullback, Says Expert
NewsMar 13, 5:05 AM ETAvi Kapoor
Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
NewsOct 31, 12:34 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Anika Reports Second Quarter 2026 Financial Results

12 Health Care Stocks Moving In Wednesday's Intraday Session

Earnings Scheduled For April 29, 2026

Anika Therapeutics Q1 Adj. EPS $0.27 Beats $(0.16) Estimate, Sales $29.612M Beat $28.142M Estimate

Anika Reports First Quarter 2026 Financial Results

Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors

Telix Strengthens Board with Additional Director Appointments

12 Health Care Stocks Moving In Monday's Pre-Market Session

Insights into Anika Therapeutics Q4 Earnings

Anika Therapeutics Q4 Adj. EPS $0.31 Beats $(0.21) Estimate, Sales $30.615M Beat $28.875M Estimate

Anika Reports Fourth Quarter and Full Year 2025 Financial Results

Lumicell Appoints Biotech and Medtech Leader Cheryl R. Blanchard, Ph.D., to Board of Directors

ANIKA INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Reminds Anika Therapeutics Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Anika Stockholders

ANIK INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Anika Therapeutics, Inc.

CFO And COO Steve Griffin to Take Over as Anika CEO While Cheryl Blanchard Becomes Executive Chair

Anika Therapeutics Announces Leadership Transition

ANIK Investigation: Investors Encouraged to Contact Kirby McInerney LLP

Anika Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors ANIK

Anika Reports Third Quarter 2025 Financial Results

ANIKA INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Reminds Anika Therapeutics Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Anika Stockholders

ANIKA (ANIK) ALERT: Bragar Eagel & Squire, P.C. is Investigating Anika Therapeutics, Inc. on Behalf of Anika Stockholders and Encourages Investors to Contact the Firm

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Anika Therapeutics, Inc. – ANIK

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK

ANIKA ALERT: Bragar Eagel & Squire, P.C. is Investigating Anika Therapeutics, Inc. on Behalf of Anika Stockholders and Encourages Investors to Contact the Firm

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK

Bragar Eagel & Squire, P.C. Is Investigating Nutex, Anika, Fluor, and Inspire Medical and Encourages Investors to Contact the Firm

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK

ANIKA (ANIK) ALERT: Bragar Eagel & Squire, P.C. Continues Investigating Anika Therapeutics, Inc. on Behalf of Anika Stockholders and Encourages Investors to Contact the Firm

US Stocks Likely To Open Lower After A Brief Respite: 'Add Exposure To Equities' Amid Pullback, Says Expert

Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket

12 Health Care Stocks Moving In Thursday's Intraday Session